跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROBITUSSIN EX SYRUP 200 MG/10 ML - HSA Drug Approval Details
Approvals
/
HSA
/
ROBITUSSIN EX SYRUP 200 MG/10 ML
Approved
THERAPEUTIC
ROBITUSSIN EX SYRUP 200 MG/10 ML
OLIC (THAILAND) LIMITED (THAILAND)
🇸🇬 Health Sciences Authority
Approval Date
Dec 2, 2002
Approval ID
28e5010e9bf07929
Company
OLIC (THAILAND) LIMITED (THAILAND)
Type
Therapeutic
Approval Details
Approval Id
28e5010e9bf07929
Drug Name
ROBITUSSIN EX SYRUP 200 MG/10 ML
Product Name
ROBITUSSIN EX SYRUP 200 MG/10 ML
Approval Number
SIN12140P
Approval Date
2002-12-02
Registrant
HALEON SINGAPORE PTE. LTD.
Licence Holder
HALEON SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CA03
Atc Item Name
guaifenesin
Pharma Manufacturer Name
gsk consumer healthcare singapore pte. ltd.
Active Ingredients
GUAIPHENESIN
200 mg/10 ml
GUAIPHENESIN
200 MG/10 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 2, 2002
Approval ID
28e5010e9bf07929
Type
Therapeutic
Back to HSA Approvals